283 related articles for article (PubMed ID: 36292936)
41. Heparin, heparan sulfate and heparanase in cancer: remedy for metastasis?
Li JP
Anticancer Agents Med Chem; 2008 Jan; 8(1):64-76. PubMed ID: 18220506
[TBL] [Abstract][Full Text] [Related]
42. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
43. Identification of iduronate-2-sulfatase in mouse pancreatic islets.
Coronado-Pons I; Novials A; Casas S; Clark A; Gomis R
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E983-90. PubMed ID: 15149955
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain.
Frese MA; Milz F; Dick M; Lamanna WC; Dierks T
J Biol Chem; 2009 Oct; 284(41):28033-28044. PubMed ID: 19666466
[TBL] [Abstract][Full Text] [Related]
45. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
Ji ZS; Fazio S; Lee YL; Mahley RW
J Biol Chem; 1994 Jan; 269(4):2764-72. PubMed ID: 8300609
[TBL] [Abstract][Full Text] [Related]
46. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
[TBL] [Abstract][Full Text] [Related]
47. Combinatorial roles of heparan sulfate proteoglycans and heparan sulfates in Caenorhabditis elegans neural development.
Kinnunen TK
PLoS One; 2014; 9(7):e102919. PubMed ID: 25054285
[TBL] [Abstract][Full Text] [Related]
48. Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.
O'Callaghan P; Zhang X; Li JP
J Histochem Cytochem; 2018 Apr; 66(4):305-319. PubMed ID: 29290138
[TBL] [Abstract][Full Text] [Related]
49. Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid.
Andrikopoulos S; Verchere CB; Teague JC; Howell WM; Fujimoto WY; Wight TN; Kahn SE
Diabetes; 1999 Oct; 48(10):1962-70. PubMed ID: 10512360
[TBL] [Abstract][Full Text] [Related]
50. Use of biosynthetic enzymes in heparin and heparan sulfate synthesis.
Chappell EP; Liu J
Bioorg Med Chem; 2013 Aug; 21(16):4786-92. PubMed ID: 23313092
[TBL] [Abstract][Full Text] [Related]
51. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
Kinsella MG; Irvin C; Reidy MA; Wight TN
Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
[TBL] [Abstract][Full Text] [Related]
52. Increased in vitro cytotoxicity of TNF-alpha analog LK-805 is based on the interaction with cell surface heparan sulfate proteoglycan.
Menart V; Fonda I; Kenig M; Porekar VG
Ann N Y Acad Sci; 2002 Nov; 973():194-206. PubMed ID: 12485860
[TBL] [Abstract][Full Text] [Related]
53. Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages.
Seo T; St Clair RW
J Lipid Res; 1997 Apr; 38(4):765-79. PubMed ID: 9144091
[TBL] [Abstract][Full Text] [Related]
54. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
Krufka A; Guimond S; Rapraeger AC
Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
[TBL] [Abstract][Full Text] [Related]
55. Perlecan in the basement membrane of corneal epithelium serves as a site for P. aeruginosa binding.
Chen LD; Hazlett LD
Curr Eye Res; 2000 Apr; 20(4):260-7. PubMed ID: 10806439
[TBL] [Abstract][Full Text] [Related]
56. The function of heparanase in diabetes and its complications.
Wang F; Wan A; Rodrigues B
Can J Diabetes; 2013 Oct; 37(5):332-8. PubMed ID: 24500561
[TBL] [Abstract][Full Text] [Related]
57. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding.
Herndon ME; Stipp CS; Lander AD
Glycobiology; 1999 Feb; 9(2):143-55. PubMed ID: 9949192
[TBL] [Abstract][Full Text] [Related]
58. Involvement of heparan sulfate 3-O-sulfotransferase isoform-1 in the insulin secretion pathway.
Takahashi I; Ohashi K; Nata K
J Diabetes Investig; 2012 Aug; 3(4):362-70. PubMed ID: 24843591
[TBL] [Abstract][Full Text] [Related]
59. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases.
Li JP; Zhang X
Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729
[TBL] [Abstract][Full Text] [Related]
60. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes.
Shibata S; Sasaki T; Harpel P; Fillit H
Clin Immunol Immunopathol; 1994 Feb; 70(2):114-23. PubMed ID: 8299226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
